Showing 12 of 12 recruiting trials for “breast-implant-associated-anaplastic-large-cell-lymphoma”
Golidocitinib Versus Placebo as Maintenance Therapy for Peripheral T-Cell Lymphoma
Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
👨⚕️ Jonathan Brammer, MD, Ohio State University Comprehensive Cancer Center📍 1 site📅 Started Feb 2026View details ↗
Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas
A Study of Alectinib and Duvelisib in People With Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma (ALK+ALCL)
👨⚕️ Robert Stuver, MD, Memorial Sloan Kettering Cancer Center📍 7 sites📅 Started Aug 2025View details ↗
Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma
Emapalumab Prevention of CAR-T Cell Associated Toxicities
A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed/Refractory Hematologic Malignancies
Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma
Study of SGR-1505 in Mature B-Cell Neoplasms
Brigatinib in Pediatric and Young Adult Patients With ALK+ ALCL, IMT or Other Solid Tumors
👨⚕️ Michel Zwaan, Prof, Princess Maxima Center for Pediatric Oncology in The Netherlands📍 2 sites📅 Started Aug 2022View details ↗
Tucidinostat, Azacitidine Combined With CHOP Versus CHOP in Patients With Untreated Peripheral T-cell Lymphoma
👨⚕️ Daobin Zhou, Department of Hematology, Peking University First Hospital📍 1 site📅 Started Oct 2021View details ↗
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →